Cart
sales@molnova.com
BIBS-39
CAS No. 133085-33-3
BIBS-39( BIBS39 | BIBS 39 )
Catalog No. M11317 CAS No. 133085-33-3
BIBS-39 is a selective nonpeptide angiotensin II receptor antagonist with Ki of 29 nM and 480 nM for AT1 and AT2 respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 71 | Get Quote |
|
| 5MG | 62 | Get Quote |
|
| 10MG | 92 | Get Quote |
|
| 25MG | 151 | Get Quote |
|
| 50MG | 217 | Get Quote |
|
| 100MG | 321 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBIBS-39
-
NoteResearch use only, not for human use.
-
Brief DescriptionBIBS-39 is a selective nonpeptide angiotensin II receptor antagonist with Ki of 29 nM and 480 nM for AT1 and AT2 respectively.
-
DescriptionBIBS-39 is a selective nonpeptide angiotensin II receptor antagonist with Ki of 29 nM and 480 nM for AT1 and AT2 respectively; shows no high affinity for other receptors, shifts the AII concentration-contractile response curves in isolated rabbit aorta with pA2 of 8.14 and a slope of 1.06; shows effective antihypertensives in the model of the renal hypertensive rat.
-
In Vitro——
-
In Vivo——
-
SynonymsBIBS39 | BIBS 39
-
PathwayGPCR/G Protein
-
TargetAngiotensin Receptor
-
RecptorAT2receptor
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number133085-33-3
-
Formula Weight524.6533
-
Molecular FormulaC32H36N4O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 32 mg/mL
-
SMILESO=C(C1=CC=CC=C1C2=CC=C(CN3C4=CC(NC(NC5CCCCC5)=O)=CC=C4N=C3CCCC)C=C2)O
-
Chemical Name[1,1'-Biphenyl]-2-carboxylic acid, 4'-[[2-butyl-6-[[(cyclohexylamino)carbonyl]amino]-1H-benzimidazol-1-yl]methyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang J, et al. Eur J Pharmacol. 1992 Jul 21;218(1):35-41.
molnova catalog
related products
-
Angiotensin II (1-4)...
Angiotensin II is a potent direct vasoconstrictor, causing arteries and veins to constrict, so leading to an increase in blood pressure. Angiotensin also potentiates the release of norepinephrine by a direct action on postganglionic sympathetic fibers.
-
EMA300
EMA300 (PD1 21981) is a potent, selective small molecule antagonist of angiotensin II type 2 receptor (AT2R).
-
Pratosartan
Pratosartan, which is an orally active angiotensin II (AII) antagonist, exhibiting selective and potent antagonistic activity to AT1 subtype. Pratosartan is a new angiotensin II type 1 receptor blocker.
